# Cidex Plus 28 Day Solution

> Active: United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/cidex-plus-28-day-solution-lrj>
- Manufacturer: [Johnson & Johnson Medical, Inc.](https://devicerts.com/manufacturers/johnson-and-johnson-medical-inc) (United States, FDA 510(k) applicant)
- Name in the registry: CIDEX PLUS 28 DAY SOLUTION
- Device class: Class I (US FDA)
- FDA product code: LRJ

## Registrations and authorizations

- **510(k)** · FDA 510(k) · United States · K923744 · decision 1994-03-29 · decision SESE · status: Active

## Recalls

No recall on record.

## Identifiers

- 510(k) Number: K923744 [FDA 510(k)]
- FDA product code: LRJ [FDA 510(k)]

## Classification

- Device class: Class I [FDA 510(k)]
- Regulation: 21 CFR Part 880.6890 [FDA 510(k)]
- Advisory committee: General Hospital [FDA 510(k)]
- FDA decision: SESE [FDA 510(k)]

## Source and citation

- Cite as: Cidex Plus 28 Day Solution, Johnson & Johnson Medical, Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/cidex-plus-28-day-solution-lrj (data as of 2026-11-21).
- Data sources: [FDA 510(k)](https://open.fda.gov/apis/device/510k/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-21
- JSON: <https://devicerts.com/devices/cidex-plus-28-day-solution-lrj.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/cidex-plus-28-day-solution-lrj
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
